These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 20035676)

  • 21. Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab' fragments.
    Casey JL; Pedley RB; King DJ; Green AJ; Yarranton GT; Begent RH
    Br J Cancer; 1999 Nov; 81(6):972-80. PubMed ID: 10576653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New insights into the pretargeting approach to image and treat tumours.
    Patra M; Zarschler K; Pietzsch HJ; Stephan H; Gasser G
    Chem Soc Rev; 2016 Nov; 45(23):6415-6431. PubMed ID: 27722526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of targeted therapies for B-cell non-Hodgkin lymphoma and multiple myeloma.
    Hernandez-Ilizaliturri FJ; Gowda A; Czuczman MS
    Clin Adv Hematol Oncol; 2004 Sep; 2(9):606-18. PubMed ID: 16163245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunotherapy with monoclonal antibodies. A new horizon in nuclear medicine therapy?
    Sautter-Bihl ML; Bihl H
    Nuklearmedizin; 1994 Aug; 33(4):167-73. PubMed ID: 7971292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioimmunotherapy for non-Hodgkin's lymphomas: a historical perspective.
    Press OW
    Semin Oncol; 2003 Apr; 30(2 Suppl 4):10-21. PubMed ID: 12728403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of radioimmunotherapy of renal cell carcinoma: labeling of monoclonal antibody cG250 with 131I, 90Y, 177Lu, or 186Re.
    Brouwers AH; van Eerd JE; Frielink C; Oosterwijk E; Oyen WJ; Corstens FH; Boerman OC
    J Nucl Med; 2004 Feb; 45(2):327-37. PubMed ID: 14960657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B; Siegel SE; Kaiser HE
    Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimizing radioimmunoconjugate delivery in the treatment of solid tumor.
    Huang CY; Pourgholami MH; Allen BJ
    Cancer Treat Rev; 2012 Nov; 38(7):854-60. PubMed ID: 22226242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in cancer therapy with radiolabeled monoclonal antibodies.
    Goldenberg DM; Sharkey RM
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):248-64. PubMed ID: 17043623
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted cancer therapy using radiolabeled monoclonal antibodies.
    Bethge WA; Sandmaier BM
    Technol Cancer Res Treat; 2005 Aug; 4(4):393-405. PubMed ID: 16029058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibody Po66 uptake by human lung tumours implanted in nude mice: effect of co-administration with doxorubicin.
    Desrues B; Léna H; Brichory F; Ramée MP; Toujas L; Delaval P; Dazord L
    Br J Cancer; 1995 Nov; 72(5):1076-82. PubMed ID: 7577450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radioimmunodetection and therapy of breast cancer.
    DeNardo SJ
    Semin Nucl Med; 2005 Apr; 35(2):143-51. PubMed ID: 15765377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoconjugates against solid tumors: mind the gap.
    Ricart AD
    Clin Pharmacol Ther; 2011 Apr; 89(4):513-23. PubMed ID: 21368753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radioimmunotherapy for hematopoietic cell transplantation.
    Jurcic JG
    Immunotherapy; 2013 Apr; 5(4):383-94. PubMed ID: 23557421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. General overview of radioimmunotherapy of solid tumors.
    Navarro-Teulon I; Lozza C; Pèlegrin A; Vivès E; Pouget JP
    Immunotherapy; 2013 May; 5(5):467-87. PubMed ID: 23638743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunotherapy for delivery of cytotoxic radioisotopes: current status and challenges.
    Martins CD; Kramer-Marek G; Oyen WJG
    Expert Opin Drug Deliv; 2018 Feb; 15(2):185-196. PubMed ID: 28893110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An overview of antibody therapy against cancer].
    Taniguchi H; Imai K
    Nihon Rinsho; 2012 Dec; 70(12):2087-92. PubMed ID: 23259378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging trends for radioimmunotherapy in solid tumors.
    Jain M; Gupta S; Kaur S; Ponnusamy MP; Batra SK
    Cancer Biother Radiopharm; 2013 Nov; 28(9):639-50. PubMed ID: 23844555
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.